Bristol Myers Squibb has ended the week with an agreement to buy Orbital Therapeutics – a developer of in vivo cell therapies – for $1.5 billion in cash. Cambridge, Massachusetts-based Orbital is ...
We measure the “warmness” of the dark matter, i.e. the comoving root-mean-square thermal velocity v hrms (1) , with nearly 3000 spiral galaxy rotation curves in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback